Netazepide, a gastrin/CCK2receptor antagonist, causes dose-dependent, persistent inhibition of the responses to pentagastrin in healthy subjects-Reference-Cited by-同舟云学术

Netazepide, a gastrin/CCK2receptor antagonist, causes dose-dependent, persistent inhibition of the responses to pentagastrin in healthy subjects

Published:2013-10-21 Issue:5 Volume:76 Page:689-698
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Boyce Malcolm¹,Warrington Steve¹,Black James²

Affiliation:

1. Hammersmith Medicines Research; Central Middlesex Hospital; London NW10 7NS UK

2. James Black Foundation; Half Moon Lane Dulwich London SE24 9JE UK

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.12099/fullpdf

Reference61 articles.

1. (3R)-N-(1-(tert-butylcarbonylmethyl)-2,3-dihydro-2-oxo-5-(2-pyridyl)-1H-1,4-benzodiazepin-3-yl)-N′-(3-(methylamino)phenyl)urea (YF476): a potent and orally active gastrin/CCK-B antagonist;Semple;J Med Chem,1997

2. YF476 is a new potent and selective gastrin/cholecystokinin-B receptor antagonist in vitro and in vivo;Takinami;Aliment Pharmacol Ther,1997

3. Effects of YF476, a potent and selective gastrin/CCK-B receptor antagonist, on gastric acid secretion in beagle dogs with gastric fistula;Takemoto;Arzneim Forsch,1998

4. Guide to receptors and channels (GRAC);Alexander;Br J Pharmacol,2011

5. Single oral doses of netazepide (YF476), a gastrin receptor antagonist, cause dose-dependent, sustained increases in 24-h gastric pH compared with placebo and ranitidine in healthy subjects;Boyce;Aliment Pharmacol Ther,2012

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The state of the art in secondary pharmacology and its impact on the safety of new medicines;Nature Reviews Drug Discovery;2024-05-21

2. Gastrin: a new branch of the gastropancreatic axis that can explain the effect of sleeve gastrectomy on glucose metabolism;Journal of Gastrointestinal Surgery;2024-04

3. Netazepide, an Antagonist of Cholecystokinin Type 2 Receptor, Prevents Vincristine-Induced Sensory Neuropathy in Mice;Pharmaceuticals;2024-01-23

4. Neuroendocrine mechanism of gastric acid secretion: Historical perspectives and recent developments in physiology and pharmacology;Journal of Neuroendocrinology;2023-06-15

5. Bromophenols from Symphyocladia latiuscula (Harvey) Yamada as Novel Cholecystokinin 2 Receptor Antagonists;Journal of Integrative Neuroscience;2023-01-05